Glucocorticoid Dose and Type are Associated with Depression Scores in Youth with Classical Congenital Adrenal Hyperplasia
PDF

Brief Report

Glucocorticoid Dose and Type are Associated with Depression Scores in Youth with Classical Congenital Adrenal Hyperplasia

J Clin Res Pediatr Endocrinol 2026;18(1):156-160 DOI: 10.4274/jcrpe.galenos.2025.2024-11-9
, , , , , ,
PDF
Permissions

Abstract

Objective

Adults with classical congenital adrenal hyperplasia (CAH) exhibit a higher lifetime prevalence of depression, but little is known about onset or etiology of mood disorders in this population. We therefore aimed to assess depression in youth with CAH, compared to controls, using the Children’s Depression Inventory (CDI).

Methods

Youth with classical CAH due to 21-hydroxylase deficiency and age- and sex-matched controls completed the CDI and had analyte and genetic testing.

Results

A total of 31 patients with CAH and 36 controls were included. Youth with CAH exhibited CDI measures that differed significantly by glucocorticoid dose and type. For glucocorticoid dose, significant correlations were found between CDI total T-score (r=0.42, p<0.05), as well as multiple subscores. Dose also predicted total T-score (β=1.75), Emotional-Problems (β=1.41), Negative-Self-Esteem (β=1.91), Functional-Problems (β=1.90), Ineffectiveness (β=1.56), and Interpersonal-Problems (β=2.11) (all p<0.01). For glucocorticoid type [dexamethasone n=7, hydrocortisone (HC) n=24], scores were higher in patients treated with dexamethasone for total T-score [dexamethasone: 59 (53.5-72), HC: 50 (43.75-55.75)], Emotional-Problems [dexamethasone: 63 (51.0-67.0), HC: 45 (42.0-56.5)], and Negative-Self-Esteem [dexamethasone: 53 (50.0-73.5), HC: 44 (44.0-51.0)] (all p<0.05).

Conclusion

Higher HC doses and use of dexamethasone were both found to be associated with higher CDI scores in children and adolescents with classical CAH.

Keywords: Depression, 21-hydroxylase deficiency, congenital adrenal hyperplasia

Read the full text

5 sections · 2 figures · 1 table · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, Meyer-Bahlburg HFL, Miller WL, Murad MH, Oberfield SE, White PC. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:4043-4088.

2

Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA, Stimson RH, Walker BR, Connell JM, Ross RJ; United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE). Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab. 2010;95:5110-5121. Epub 2010 Aug 18

3

Falhammar H, Butwicka A, Landén M, Lichtenstein P, Nordenskjöld A, Nordenström A, Frisén L. Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2014;99:E554-E560. Epub 2013 Dec 3

4

Van’t Westeinde A, Karlsson L, Thomsen Sandberg M, Nordenström A, Padilla N, Lajic S. Altered gray matter structure and white matter microstructure in patients with congenital adrenal hyperplasia: relevance for working memory performance. Cereb Cortex. 2020;30:2777-2788.

5

Herting MM, Azad A, Kim R, Tyszka JM, Geffner ME, Kim MS. Brain differences in the prefrontal cortex, amygdala, and hippocampus in youth with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2020;105:1098-1111.

6

Cotter DL, Azad A, Cabeen RP, Kim MS, Geffner ME, Sepehrband F, Herting MM. White matter microstructural differences in youth with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2021;106:3196-3212.

7

Barch DM, Hua X, Kandala S, Harms MP, Sanders A, Brady R, Tillman R, Luby JL. White matter alterations associated with lifetime and current depression in adolescents: evidence for cingulum disruptions. Depress Anxiety. 2022;39:881-890. Epub 2022 Nov 2

8

Jacob M, Lin-Su K, Catarozoli C, Thomas C, Poppas D, Lekarev O. Screening for anxiety and depression in children with congenital adrenal hyperplasia. J Clin Res Pediatr Endocrinol. 2023;15:406-416. Epub 2023 Jul 20

9

Harasymiw LA, Grosse SD, Cullen KR, Bitsko RH, Perou R, Sarafoglou K. Depressive and anxiety disorders and antidepressant prescriptions among insured children and young adults with congenital adrenal hyperplasia in the United States. Front Endocrinol (Lausanne). 2023;14:1129584.

10

Kovacs, M. Children’s depression inventory (CDI and CDI 2). In: Cautin RL, Lilienfeld SO, editors. The Encyclopedia of Clinical Psychology. Hoboken (NJ): Wiley; 2015:1-5.

11

Weber J, Tanawattanacharoen VK, Seagroves A, Liang MC, Koppin CM, Ross HM, Bachega TASS, Geffner ME, Serrano-Gonzalez M, Bhullar G, Kim MS. Low adrenomedullary function predicts acute illness in infants with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2022;107:e264-e271.

12

Hassanein S, Badawi N, Afifi D, Gamal R, Ibrahim A. Depression and anxiety in children with congenital adrenal hyperplasia. Pediatr Sci J. 2022;2:193-202.

13

Tiemensma J, Biermasz NR, Middelkoop HA, van der Mast RC, Romijn JA, Pereira AM. Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing’s disease. J Clin Endocrinol Metab. 2010;95:E129-E141. Epub 2010 Jul 21

14

Mrakotsky C, Forbes PW, Bernstein JH, Grand RJ, Bousvaros A, Szigethy E, Waber DP. Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease. J Int Neuropsychol Soc. 2013;19:96-109. Epub 2012 Nov 19